Meeting Clients Where They Are: Using a Neuro-Informed Lens
This session is co-sponsored by the Fetal Alcohol & Drug Unit at the UW Addictions, Drug & Alcohol Institute (FADU at ADAI).
Clinicians, case managers and other social and human service workers are often familiar with the concepts of trauma-informed care, and while our work has greatly benefitted from the initial shift from approaching our work with the question "what's wrong with you?" to "what happened to you?" the time has arrived to widen our perspective and practices and adopt a "neuro-informed" approach to building effective helping relationships. This webinar is not about tossing out the wisdom of trauma-informed approaches but rather about expanding the insight into working with the whole person and unique predicting brain. In this session, participants will be presented with an overview of the predicting brain model based on the work of Lisa Feldman Barrett and have the opportunity to reflect on how to integrate a neuro-informed view into already existing trauma-informed approaches in building…
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/webinar/register/WN__adJrFgGTZ6sX5i4vPnmKA. Accessibility Contact: Meg Brunner meganw@uw.edu. Event Types: Lectures/Seminars.
Wednesday, December 3, 2025, 12:00 PM – 1:00 PM.
Webinar - Register at: https://washington.zoom.us/webinar/register/WN__adJrFgGTZ6sX5i4vPnmKA.
ADAI Lunch & Learn: Of Mice and Misuse: Preclinical Modeling of Fentanyl Use Disorder
Presenter:
Kevin Coffey, PhD. Research Assistant Professor, UW Psychiatry & Behavioral Sciences
Kevin Coffey is a Research Assistant Professor in Psychiatry and Behavioral Sciences at the University of Washington and a MIRECC Investigator at the VA Puget Sound. His lab aims to identify the neural mechanisms underlying substance use disorders and maladaptive decision making. Dr. Coffey’s current focus is on studying the neurobiological consequences and predictors of chronic fentanyl use. To accomplish this, his lab utilizes cutting-edge in-vivo optical neuroscience tools (photometry, optogenetics, MiniScopes, etc.) along with a newly developed oral fentanyl self-administration model for rats and mice. His recently funded ADAI pilot grant aims to explore the use of the GLP-1R agonist dulaglutide for treatment of fentanyl use disorder in his rodent models.
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/meeting/register/R2E_CapZRbybpRYqz3fewA#/registration. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars.
Thursday, January 29, 2026, 12:00 PM – 1:00 PM.
Webinar - register at: https://washington.zoom.us/meeting/register/R2E_CapZRbybpRYqz3fewA#/registration.
For more info visit washington.zoom.us.